Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Geranylgeranyl transferase type I | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | 0.0246 | 0.1928 | 0.1868 | |
Brugia malayi | fructose-1,6-bisphosphatase | 0.0484 | 0.5414 | 0.5414 |
Leishmania major | 0.0484 | 0.5414 | 0.5 | |
Schistosoma mansoni | tyrosine kinase | 0.0428 | 0.459 | 0.455 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0254 | 0.2045 | 0.1986 |
Schistosoma mansoni | tyrosine kinase | 0.0423 | 0.4524 | 0.4484 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0796 | 1 | 1 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.0484 | 0.5414 | 0.5414 |
Entamoeba histolytica | geranylgeranyl transferase beta subunit | 0.012 | 0.0074 | 0.5 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.0484 | 0.5414 | 0.538 |
Schistosoma mansoni | tyrosine kinase | 0.0254 | 0.2045 | 0.1986 |
Echinococcus granulosus | insulin receptor | 0.0254 | 0.2045 | 0.1986 |
Toxoplasma gondii | fructose-bisphospatase II | 0.0484 | 0.5414 | 1 |
Trichomonas vaginalis | geranylgeranyl transferase type I beta subunit, putative | 0.012 | 0.0074 | 0.5 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0428 | 0.459 | 0.455 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.0484 | 0.5414 | 1 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.0484 | 0.5414 | 0.538 |
Loa Loa (eye worm) | prenyltransferase and squalene oxidase repeat family protein | 0.012 | 0.0074 | 0.0074 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0796 | 1 | 1 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0254 | 0.2045 | 0.2045 |
Schistosoma mansoni | tyrosine kinase | 0.0254 | 0.2045 | 0.1986 |
Echinococcus multilocularis | insulin receptor | 0.0254 | 0.2045 | 0.1986 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0484 | 0.5414 | 1 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0428 | 0.459 | 0.455 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0484 | 0.5414 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0796 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0428 | 0.459 | 0.455 |
Schistosoma mansoni | tyrosine kinase | 0.0796 | 1 | 1 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.0484 | 0.5414 | 0.538 |
Brugia malayi | Protein kinase domain containing protein | 0.0254 | 0.2045 | 0.2045 |
Schistosoma mansoni | tyrosine kinase | 0.0423 | 0.4524 | 0.4484 |
Brugia malayi | Prenyltransferase and squalene oxidase repeat family protein | 0.012 | 0.0074 | 0.0074 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0254 | 0.2045 | 0.1986 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0428 | 0.459 | 0.455 |
Schistosoma mansoni | tyrosine kinase | 0.0423 | 0.4524 | 0.4484 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | 0 nM | Reduced farnesylation of H-ras transformed NIH3T3 cells; ND=Not determined | ChEMBL. | 15324873 |
IC50 (binding) | = 11 nM | Inhibition of [3H]-FPP incorporation into biotin-linked K-ras decapeptide (CVIM) by bovine farnesyltransferase | ChEMBL. | 15324873 |
IC50 (binding) | = 6200 nM | inhibitory concentration needed to to reduce the bovine GGTase-catalyzed incorporation of [3H]-FPP into a biotin-linked K-ras (B) decapeptide | ChEMBL. | 15324873 |
IC50 (binding) | = 6200 nM | inhibitory concentration needed to to reduce the bovine GGTase-catalyzed incorporation of [3H]-FPP into a biotin-linked K-ras (B) decapeptide | ChEMBL. | 15324873 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.